FIELD: medicine, clinical pharmacology, biochemistry.
SUBSTANCE: invention proposes the developed method for prognostication of effectiveness of angiotensin-converting enzyme inhibitors that involves determination of blood serum concentration of diene conjugates. Method involves additional determination of the parent indices of heart state in patient: systolic arterial pressure, final systolic volume, final diastolic volume of left ventricle and these indices are determined during carrying out the orthostatic test. Patient is examined on orthotable with shifting the orthotable head end up by 60o and kept in this position for 10 min. On 5-th min of orthostatic position heart state indices are determined in the patient again followed by calculations of the venous reflux coefficient (KVR) is measured by the formula and coefficient of vascular response (Kvr) also. The favorable result for effectiveness in using preparations of the group of angiotensin-converting enzyme inhibitors is determined at value KVR from 0.7 to 0.95 and value Kvr from 0.8 to 0.95, and the concentration of diene conjugates less 10 mcM/ml. Method provides assay of quantitative evaluation of individual sensitivity of patient to preparations of the group of angiotensin-converting enzyme inhibitors.
EFFECT: improved method for prognostication.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSAY OF INDIVIDUAL SENSITIVITY TO CALCIUM ANTAGONIST AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN ARTERIAL HYPERTENSION | 2003 |
|
RU2264625C2 |
METHOD FOR INDIVIDUAL SELECTION OF DRUG PREPARATIONS IN THERAPY OF ARTERIAL HYPERTENSION | 2011 |
|
RU2477974C2 |
METHOD OF OPTIMIZATION OF TREATMENT OF WOMEN BY CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY FOR ESTROGENDEFICIENCY WITH HYPERTENSION IN THE LATE REPRODUCTIVE PERIOD | 2016 |
|
RU2648470C2 |
METHOD FOR OPTIMISATION OF MEN CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY IN CASE OF ANDROGENODEFICIENCY WITH ARTERIAL HYPERTENSION | 2016 |
|
RU2632449C1 |
METHOD FOR ESTIMATING EFFICACY OF THERAPY OF PRIMARY HYPERTENSION | 2009 |
|
RU2412653C1 |
METHOD FOR PREDICTION OF RISK OF RENAL VENOUS BLOOD FLOW DISTURBANCE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2024 |
|
RU2824420C1 |
METHOD FOR ASSESSING NEUROCIRCULATORY DYSTONIA PATIENT TREATMENT EFFECTIVENESS | 1998 |
|
RU2165236C2 |
METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
METHOD OF TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION | 1998 |
|
RU2164410C2 |
Authors
Dates
2004-09-27—Published
2002-12-04—Filed